Abstract
Background The outbreak of coronavirus disease 2019 (COVID-19) has placed unprecedented challenges on hospital environmental hygiene and medical staff protection. It is crucial to assess hospital environmental hygiene to understand the most important environmental issues for controlling the spread of COVID-19 in hospitals.
Objective To detect the presence of COVID-19 in the samples from the area at risk of contamination in the First Hospital of Jilin University.
Methods Viruses in the air were collected by natural sedimentation and air particle sampler methods. Predetermined environmental surfaces were sampled using swabs at seven o’clock in the morning before disinfection. The real-time reverse-transcription PCR method was used to detect the existence of COVID-19 pathogens.
Results Viruses could be detected on the surfaces of the nurse station in the isolation area with suspected patients and in the air of the isolation ward with an intensive care patient.
Conclusion Comprehensive monitoring of hospital environmental hygiene during pandemic outbreaks is conducive to the refinement of hospital infection control. It is of great significance to ensure the safety of medical treatment and the quality of hospital infection control through the monitoring of environmental hygiene.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
the National Natural Science Foundation of China (Nos. 30972610 and 81273240), Jilin Province Science and Technology Agency (Nos. 20160101037JC, 20170622009JC, 2017C021, and 2017J039), Norman Bethune Program of Jilin University (2012206), and Open Project Funding from State Key Laboratory of Kidney Diseases.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Yanfang Jiang yanfangjiang{at}hotmail.com
Haifeng Wang wanghaifeng1994{at}163.com
Yukun Chen cyk0503{at}qq.com
Jiaxue He jiaxue-he{at}163.com
Liguo Chen 123043714{at}qq.com
Yong Liu 530440980{at}qq.com
Xinyuan Hu 1586878478{at}qq.com
Ang Li li987001500{at}qq.com
Siwen Liu 530229652{at}qq.com
Peng Zhang 123126672{at}qq.com
Hongyan Zou 2361044502{at}qq.com
Data Availability
All data, models, and code generated or used during the study appear in the submitted article.